Nalaganje...
Prescription of Pneumocystis jiroveci pneumonia prophylaxis in HIV-infected patients
U.S. treatment guidelines recommend Pneumocystis jiroveci pneumonia (PCP) prophylaxis for all HIV-infected persons with CD4+ T-lymphocyte (CD4) counts <200 cells/μl (i.e. eligible for PCP prophylaxis). However, some studies suggest PCP prophylaxis may be unnecessary in virally suppressed patients...
Shranjeno v:
| izdano v: | J Int Assoc Provid AIDS Care |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5310212/ https://ncbi.nlm.nih.gov/pubmed/27629868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2325957416667486 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|